site stats

Jounce stock price

Nettet9. apr. 2024 · The stock was sold at an average price of $1.10, for a total transaction of $22,210.10. Jounce Therapeutics Stock Down 0.5 % NASDAQ:JNCE opened at $1.89 on Friday. NettetJounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T ...

JNCE: Jounce Therapeutics Inc - Stock Price, Quote and News

NettetJounce Therapeutics Driven by Science. Motivated by Patients. about About Jounce Management Board of Directors Company Founders our approach Focus on Patients … NettetView live Jounce Therapeutics, Inc chart to track its stock's price action. Find market predictions, JNCE financials and market news. dijkstra 2007 https://aplustron.com

JNCE Jounce Therapeutics Inc. Stock Price & News - WSJ

Nettet27. mar. 2024 · JOUNCE THERAPEUTICS, INC. (Name of Person (s) Filing Statement) Common Stock, $0.001 par value per share (Title of Class of Securities) 481116101 (CUSIP Number of Common Stock) Jacquelyn... Nettet14. apr. 2024 · Five investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat, … NettetJounce Therapeutics (JNCE) is set to be acquired by Concentra Biosciences, spurning an all-share merger deal with British biotech firm Redx Pharma. CRSP : 45.40 (+1.34%) JNCE : 1.8900 (-0.53%) CERT : 23.01 (+0.52%) EQRX : 1.8900 (+2.72%) SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVT, USX, JNCE … dijkslag lopik

Why did Jounce Therapeutics stock go up today? - MarketBeat

Category:Why did Jounce Therapeutics stock go up today? - MarketBeat

Tags:Jounce stock price

Jounce stock price

JNCE Stock Price and Chart — NASDAQ:JNCE — TradingView

Nettet12. apr. 2024 · The average twelve-month price prediction for Jounce Therapeutics is $6.00 with a high price target of $11.00 and a low price target of $3.00. Do Wall Street analysts like Jounce Therapeutics more than its competitors? Analysts like Jounce Therapeutics less than other Medical companies. Nettet6. apr. 2024 · Jounce Therapeutics stock price target cut to $12 from $28 at J.P. Morgan Jun. 4, 2024 at 7:58 a.m. ET by Tomi Kilgore Jounce Therapeutics downgraded to …

Jounce stock price

Did you know?

Nettet29. des. 2024 · Jounce’s cash position at the end of September 2024 was $130.3 million compared to $220.2 million as of December 31, 2024. That means its cash burn is quite high, with approximately $120 million... Nettet15. mar. 2024 · News Jounce Therapeutics Inc. Significant News Only No significant news for JNCE in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-0.99 Market Cap $96.46 M Shares...

Nettet102 rader · 30. mar. 2024 · Discover historical prices for JNCE stock on Yahoo Finance. View daily, weekly or monthly format back to when Jounce Therapeutics, Inc. stock … Nettet4. apr. 2024 · JOUNCE THERAPEUTICS, INC. : JNCE Stock Price US4811161011 MarketScreener Homepage Equities United States Nasdaq Jounce Therapeutics, Inc. …

NettetCurrent and historical p/e ratio for Jounce Therapeutics (JNCE) from 2015 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Nettet6. apr. 2024 · JNCE - Jounce Therapeutics Inc Stock Price Quote - NASDAQ Morningstar Jounce Therapeutics Inc JNCE Stock Quote Morningstar Rating Rating as of Mar 31, 2024 Quote Chart Stock...

Nettet7. mar. 2024 · Jounce Therapeutics Inc. (NASDAQ:JNCE) traded at $1.06 at last check on Tuesday, March 07, made a downward move of -1.85% on its previous day’s price. Looking at the stock we see that its previous close was $1.08 and the beta (5Y monthly) reads 0.65 with the day’s price range being $1.01

NettetJounce Therapeutics, Inc. (JNCE) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 1.8600 -0.0300 (-1.59%) As of 03:43PM EDT. Market open. … beau willimon linkedinNettet6. apr. 2024 · See the latest Jounce Therapeutics Inc stock price (NASDAQ:JNCE), related news, valuation, dividends and more to help you make your investing decisions. beau williams songsNettet31. mar. 2024 · nasdaq.com - October 17 at 3:31 PM. Jounce Therapeutics to Participate in the Upcoming Investor Conferences. finance.yahoo.com - September 7 at 9:45 AM. Jounce (JNCE) SELECT Study Fails to Meet Goal, Stock Down. nasdaq.com - August 31 at 12:04 PM. Jounce Therapeutics Shares Fall After Disappointing Mid-Stage Lung … beau willimon wikipediaNettet31. mar. 2024 · Complete Jounce Therapeutics Inc. stock information by Barron's. View real-time JNCE stock price and news, along with industry-best analysis. beau wyattdijkstra 2010Nettet10. apr. 2024 · Jounce Therapeutics stock bounces after saying only 1.4% of its cash was in an SVB operating account. Shares of Jounce Therapeutics Inc. JNCE, -6.09% … beau yakichNettet27. mar. 2024 · Presently, Jounce Therapeutics Inc. shares are logging -76.62% during the 52-week period from high price, and 221.50% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.58 and $7.94. beau yancey